Author Response: “Do PPIs Blunt the Treatment Effect of Romosozumab?”
Osteoporosis International · 10.11.2026
DOI: 10.1007/s00198-026-08321-x ↗Kurz gefasst
Leserbrief in der Zeitschrift Osteoporosis International, online erschienen am 10.11.2026. Verfasst von Felix N von Brackel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- MVZ Osteologie, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. r.oheim@uke.de.
Zitieren
APA
von Brackel, F. N., Dehne, N., Günzl, C., Barvencik, F., & Oheim, R. (2026). Author Response: “Do PPIs Blunt the Treatment Effect of Romosozumab?”. Osteoporosis International. https://doi.org/10.1007/s00198-026-08321-x
Vancouver
von Brackel FN, Dehne N, Günzl C, Barvencik F, Oheim R. Author Response: “Do PPIs Blunt the Treatment Effect of Romosozumab?”. Osteoporosis International. 2026. doi:10.1007/s00198-026-08321-x
BibTeX
@article{vonBrackel2026,
author = {von Brackel, Felix N and Dehne, Nicolas and Günzl, Claudia and Barvencik, Florian and Oheim, Ralf},
title = {Author Response: “Do PPIs Blunt the Treatment Effect of Romosozumab?”},
journal = {Osteoporosis International},
year = {2026},
doi = {10.1007/s00198-026-08321-x}
}
EUVIMED